Supernus Pharmaceuticals, Inc. (SUPN) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree, a non-stimulant indicated for the treatment of attention-deficit…
Source: Yahoo Finance
Sector & Industry
Supernus Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Supernus Pharmaceuticals, Inc. at a Glance
| Company | Supernus Pharmaceuticals, Inc. |
| Ticker | SUPN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $43.53 |
| Market cap | $2.53B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.92 |
| 52-week high | $59.68 |
| 52-week low | $42.45 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.56 |
| Return on equity (ROE) | -10.49% |
| Debt-to-equity | 3.90% |
| Average volume | 839,828 |
| Shares outstanding | 58.13M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 778 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Supernus Pharmaceuticals, Inc.'s current P/E ratio?
- Supernus Pharmaceuticals, Inc. (SUPN) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Supernus Pharmaceuticals, Inc.'s market capitalisation?
- Supernus Pharmaceuticals, Inc.'s market cap is $2.53B based on our latest snapshot. See how it ranks by market cap →
- What is SUPN's 52-week range?
- Over the past 52 weeks, SUPN has traded between $42.45 and $59.68. What does the 52-week range mean? →
- How volatile is Supernus Pharmaceuticals, Inc. compared to the market?
- Supernus Pharmaceuticals, Inc. has a beta of 0.56, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Supernus Pharmaceuticals, Inc. pay a dividend?
- Supernus Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is SUPN listed on?
- SUPN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Supernus Pharmaceuticals, Inc. in?
- Supernus Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →